IXDen Overview
IXDen has developed a single AI platform for OT failure prediction and IoT cybersecurity, including the world’s first “biometric” identity for industrial control systems (ICS). IXDen's solution approach to OT system protection covers Industrial IoT cybersecurity and sensor data integrity. Leveraging patented biometric IoT device identity and multifactor authentication, IXDen achieves sensor data integrity on a sensor level while providing at-the-source threat detection. IXDen has developed a software-only anomaly-detection and multifactor device authentication system based on proprietary algorithms and patented AI. Its platform enables customers to have full visibility into the health of their enterprise; manage the security levels of their networks, 100% of their sensors and programmable logic controllers (PLC); predict equipment failures; and save millions of dollars by identifying and mitigating breaches of data integrity in real time. IXDen’s biometric, identity-based and patented system addresses both cybersecurity and operational demands as the core technology constantly tracks all of the sensors’ data and changes, ensuring that any malfunctions or anomalies are recorded and addressed. IXDen leverages proprietary behavioral and mathematical algorithms, statistical analysis, machine learning, and patented artificial intelligence to model the behavior of various industrial physical systems, attaining deep understanding of the device data, software, and hardware. The solution provides data veracity and device security without any hardware or security keys stored on the device. IXDen offers OT teams the system health indicator, reflecting the health of the data and security level, enabling better prediction of potential system misbehavior. The company serves diverse markets and sectors, including water, energy, gas, oil. The product is in production in over 100 water sites in the Israel's national water company, Mekorot.
Cumulative Funding Raised Over Time ($)
Latest News
| Sector | Cyber Security |
Funding
| Total funding | $7.5M |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 6 |
| Investors | 7 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | ixden.com/ |
Locations
11 Menachem Begin, Rogovin Tidhar Tower Ramat Gan, Israel
Houston, TX, USA
Photos & Videos
1 item(s)
IXDen Business
Sector
Cyber SecurityIndustrial SecurityIndustrial TechnologiesProcess Automation & Intelligence SystemsTarget Customer
Energy, Utilities & Waste ManagementUtilitiesWater UtilitiesElectricityGas UtilitiesIndustrial ManufacturingCore Technology
CommunicationsIOTPlatforms & InterfacesSoftwareTags (21)
monitoringoil-and-gas-companiesdata-protectioniotmachine-learningcritical-infastructuresmart-citysensorsbiometricsartificial-intelligenceauthenticationcyber-securityidentity-verificationelectric-utilitiesgas-utilitieswaterbehavior-analyticssmart-gridwater-utilitiescontrol-systemsindustry-4.0Geographic Markets
EuropeNorth AmericaIXDen Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
IXDen Lifecycle
Cumulative Funding Raised Over Time
All Events
IXDen News
7 articlesIXDen Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 14 classification IDs that could be used for matching.
IXDen Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515733848 |
| Crunchbase | ix-den |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-11-15T00:00:00.000Z |
| Created | 2017-04-26T00:00:00.000Z |
| Claimed | Yes |